T-cell subpopulations express a different pattern of dopaminergic markers in intra-and extra-thymic compartments

Journal of Biological Regulators and Homeostatic Agents

Volumn 27, Issue 2, 2013, Pages 463-475

  Mignini, Fiorenzo ^a   Sabbatini, M ^b   Capacchietti, M ^a   Amantini, C ^a   Bianchi, E ^c   Artico, M ^c   Tammaro, A ^c  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dopamine receptors; Dopamine transporters; Lymphocytes; Splenocytes; Thymocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 1; VESICULAR MONOAMINE TRANSPORTER 2; BIOLOGICAL MARKER; DOPAMINE; SLC18A1 PROTEIN, RAT; SLC18A2 PROTEIN, RAT; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; FLUORESCENCE ACTIVATED CELL SORTING; MALE; MEMBRANE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; THYMOCYTE; THYMUS; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHEMISTRY; FLOW CYTOMETRY; IMMUNOLOGY; PHYSIOLOGY; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELLS, CULTURED; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FLOW CYTOMETRY; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; T-LYMPHOCYTE SUBSETS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84883476503     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Hayday AC, Pennington DJ. Key factors in the organized chaos of early T cell development. Nat Immunol 2007; 8:137-44. (Pubitemid 46152644)
2. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52:595-38.
3. Basu S, Dasgupta PS, Lahiri T, Chowdhury JR. Uptake and biodistribution of dopamine in bone marrow, spleen and lymph nodes of normal and tumor bearing mice. Life Sci 1993; 53:415-24.
4. Leposavić G, Pilipović I, Radojević K, Pesić V, Perisić M, Kosec, D. Catecholamines as immunomodulators: a role for adrenoceptor-mediated mechanisms in fine tuning of T-cell development. Auton Neurosci 2008; 144:1-12.
5. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S. The immunoregulatory role of dopamine: an update. Brain Behav Immun 2010; 24:525-8.
6. Buttarelli FR, Fanciulli A, Pellicano C, Pontieri FE. The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr Neuropharmacol 2011; 9:278-88.
7. Basu S, Dasgupta PS. Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000; 102:113-24.
8. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 2002; 132:34-40. (Pubitemid 35333323)
9. Cosentino M, Rasini E, Colombo C. Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med 2004; 36:1233-40. (Pubitemid 38526317)
10. Kirillova GP, Hrutkay RJ, Shurin MR, Shurin GV, Tourkova IL, Vanyukov MM. Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays. J Neurosci Methods 2008; 174:272-80.
11. Ricci A, Mariotta S, Greco S, Bisetti A. Expression of dopamine receptors in immune organs and circulating immune cells. Clin Exp Hypertens 1997; 19:59-71. (Pubitemid 27084525)
12. Amenta F, Bronzetti E, Cantalamessa F, El-Assouad D, Felici L, Ricci A, Tayebati SK. Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J Neuroimmunol 2001; 117:133-42. (Pubitemid 32595500)
13. Amenta F, Ricci A, Tayebati SK, Zaccheo D. The peripheral dopaminergic system: morphological analysis, functional and clinical applications. Ital J Anat Embryol 2002;107:145-67.
14. Li HZ, Han LP, Jiang CM, et al. Effect of dopamine receptor 1 on apoptosis of cultured neonatal rat cardiomyocytes in simulated ischaemia/reperfusion. Basic Clin Pharmacol Toxicol 2008;102:329-36.
15. Moreira-Rodrigues M, Sampaio-Maia B, Pestana M. Renal dopaminergic system activity in rat remnant kidney up to twenty-six weeks after surgery. Life Sci 2009; 84:409-14.
16. Zeng C, Han Y, Huang H, et al. D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression. J Hypertens 2009; 27:1033-41.
17. Jin XH, Zhang JZ, Zhao YJ, Zhao RR. Localization of dopamine 1A receptor mRNA in different vascular beds in rat: a nonradioactive in situ hybridization study. Methods Find Exp Clin Pharmacol 1997;19:657-3.
18. Cavallotti C, Mancone M, Bruzzone P, Sabbatini M, Mignini F. Dopamine receptor subtypes in the native human heart. Heart Vessels 2010;25:432-7.
19. Hani T, Ben-Shachar D, Strous RD, Mazor M, Sheinkman A, Kotler M, Fuchs S. A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci U S A 2001;98:625-8. (Pubitemid 32105093)
20. Brito-Melo GE, Nicolato R, de Oliveira AC, et al. Increase in dopaminergic, but not serotoninergic, receptors in T-cells as a marker for schizophrenia severity. J Psychiatr Res 2012; 46(6):738-42.
21. Wandinger KP, Hagenah JM, Klüter H, Rothermundt M, Peters M, Vieregge P. Effects of amantadine treatment on in vitro production of interleukin-2 in de-novo patients with idiopathic Parkinson's disease. J Neuroimmunol 1999; 98:214-20. (Pubitemid 29317548)
22. Katsanos GS, Anogianaki A, Castellani ML, et al. Biology of neurotensin: revisited study. Int J Immunopathol Pharmacol 2008; 21:255-9. (Pubitemid 351988386)
23. Mignini F, Sabbatini M, D'Andrea V, Cavallotti C. Neuropeptides of human thymus in normal and pathological conditions. Peptides 2011; 32:920-8
24. Mignini F, Traini E, Tomassoni D, Amenta F. Dopamine plasma membrane transporter (DAT) in rat thymus and spleen: an immunochemical and immunohistochemical study. Auton Autacoid Pharmacol 2006; 26:183-9.
25. Mignini F, Tomassoni D, Traini E, Amenta F. Dopamine, vesicular transporters and dopamine receptor expression and localization in rat thymus and spleen. J Neuroimmunol 2009; 206:5-13.
26. Mignini F, Sabbatini M, D'Andrea V, Cavallotti C. Intrinsic innervation and dopaminergic markers after experimental denervation in rat thymus. Eur J Histochem 2010; 54:e17.
27. Nakano K, Higashi T, Takagi R, Hashimoto K, Tanaka Y, Matsushita S. Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 2009; 21:645-4.
28. Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S. The immunoregulatory role of dopamine: an update. Brain Behav Immun 2010; 24:525-8.
29. Cosentino M, Fietta AM, Ferrari M, et al. Human CD4+CD25+ regulatory T cells selectively express tyrosine hydroxylase and contain endogeneous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 2007; 109:632-42. (Pubitemid 46105964)
30. Sarkar C, Das S, Chakroborty D, Chowdhury UR, Basu B, Dasgupta PS, Basu S. Cutting Edge: Stimulation of dopamine D4 receptors induce T cell quiescence by up-regulating Kruppel-like factor-2 expression through inhibition of ERK1/ERK2 phosphorylation. J Immunol 2006; 177:7525-9. (Pubitemid 44846267)
31. Besser MJ, Ganor Y, Levite M. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF alpha or both. J Neuroimmunol 2005; 169:161-71. (Pubitemid 41528789)
32. Ilani T, Strous RD, Fuchs S. Dopaminergic regulation of immune cells via D3 dopamine receptor: a pathway mediated by activated T cells. FASEB J 2004; 18:1600-2. (Pubitemid 39561646)
33. Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 2008; 8:460-71.